Adagene logo

Adagene

Redefining the design and discovery of therapeutic antibodies

82 employees · est. 2012

VS
HiberCell logo

HiberCell

Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis

25 employees · est. 2019 · New York, United States

Adagene is the older company (2012 vs 2019); Adagene is the larger of the two.

Side-by-Side Comparison

Adagene HiberCell
Founded
2012 older 2019
Headquarters
Not tracked yet New York, United States
Employees
82 larger 25
Industry
Biotechnology, Health and Wellness Biotechnology, Health Care
Funding Stage
IPO Unknown
Total Funding
$390.00M $128.20M
Funding Rounds
8 2
Services
Antibody Discovery, Antibody Engineering, Drug Development Development of therapeutic candidates (HC-7366, HC-5404), Clinical-stage research and trials, Exploiting stress-driven vulnerabilities in cancer cells
Target Customers
Pharmaceutical Companies, Healthcare Institutions, Biotech Investors Cancer patients, Healthcare providers, Biotech investors, Oncologists
Taxonomy
Antibody Discovery, Cancer Immunotherapy, Computational Biology, DPL Platform, NEObody Technology, SAFEbody Technology, POWERbody Technology, Immuno-oncology, Novel Epitopes, Smart Antibody Technology, Clinical-stage Biotech, Therapeutic Antibody Development, Strategic Collaborations Oncology, Therapeutics, Cancer, Metastasis, Clinical Stage, Adaptive Stress Pathways, Anti-tumor Immunity, Product Candidates, Phase 1a Clinical Trials, Cancer Relapse Prevention, New York, Treatment Resistance, Stress Response Kinases, Innate Immune Response
Website
adagene.com hibercell.com
Adagene logo

About Adagene

Adagene Inc. (Nasdaq: ADAG) is a pioneering biotechnology company established in 2012, with a commitment to transforming the design and discovery of antibody-based cancer immunotherapies. The company’s slogan, "Redefining the design and discovery of therapeutic antibodies," underscores its innovativ...

HiberCell logo

About HiberCell

HiberCell, founded in 2019 and headquartered in the United States, is a pioneering force in the Biotechnology and Health Care industries. With a focus on developing novel therapeutics, the company aims to prevent cancer relapse and metastasis. Its slogan, "Developing Novel Therapeutics to Prevent Ca...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Adagene and HiberCell — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Adagene and HiberCell — by email.

Frequently Asked Questions

Adagene — Redefining the design and discovery of therapeutic antibodies. HiberCell — Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Adagene has raised $390.00M while HiberCell has raised $128.20M.
Adagene and HiberCell operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Adagene with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy